All abstracts should be formatted into the following four sections:

• Introduction: clarifies the motivation for the research presented.
• Methods: provides sufficient detail for others to reproduce what is studied in the research project.
• Results: presents and discusses the results.
• Conclusion: presents the outcome of the work by interpreting the findings and by relating these findings to the motivation stated in the Introduction. Explain the significance of your findings / outcomes and future implications of the results.

All abstracts must be submitted electronically through the Congress abstract submission website.

• Abstracts will be accepted in English only.
• There is no fee for submitting an abstract.
• There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present two abstracts (oral, mini-oral or poster) presentations during the entire Congress. If you have more than 2 abstracts accepted, you will be obliged to identify alternate co-author for any abstract above the first two.
• The abstract text body is limited to 3,000 characters (Approx. 400 words) including spaces. A maximum of two figures/images (in JPG, GIF, or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure.
• Tables: do not insert tables into the body of the abstracts, the system will not recognize the format of the table. Tables will need to be uploaded as image files into the body of the abstract.
• Abstracts accepted for oral, mini-oral or poster presentation will be published electronically in Pediatric Transplantation, the official journal of the International Pediatric Transplant Association. Abstracts not accepted for presentation will not be published. Abstracts will also be posted prior to the meeting in the detailed program section of the Congress website.
• Employees of Commercial Interests: IPTA recognizes that employees/spouses of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial interests should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
• Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after April 8, 2025. Once an abstract has been scored by reviewers, no change in the body of the abstract will be accepted.
• Presenters of successful abstracts must confirm their acceptance, register and pay for the Congress by June 15, 2025, otherwise the abstract will not be published.